Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Healthcare Services (HCSG) EBITDA: 2009-2025

Historic EBITDA for Healthcare Services (HCSG) over the last 17 years, with Q3 2025 value amounting to $43.7 million.

  • Healthcare Services' EBITDA rose 17083.05% to $43.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $87.6 million, marking a year-over-year increase of 7236.04%. This contributed to the annual value of $39.0 million for FY2024, which is 255.13% down from last year.
  • Per Healthcare Services' latest filing, its EBITDA stood at $43.7 million for Q3 2025, which was up 17083.05% from $17.7 million recorded in Q1 2025.
  • Healthcare Services' EBITDA's 5-year high stood at $43.7 million during Q3 2025, with a 5-year trough of -$6.7 million in Q3 2023.
  • Moreover, its 5-year median value for EBITDA was $10.3 million (2021), whereas its average is $12.7 million.
  • Its EBITDA has fluctuated over the past 5 years, first plummeted by 23962.46% in 2023, then soared by 34085.75% in 2024.
  • Healthcare Services' EBITDA (Quarter) stood at $4.8 million in 2021, then skyrocketed by 270.57% to $17.8 million in 2022, then soared by 48.53% to $26.4 million in 2023, then plummeted by 61.7% to $10.1 million in 2024, then skyrocketed by 331.18% to $43.7 million in 2025.
  • Its EBITDA stands at $43.7 million for Q3 2025, versus $17.7 million for Q1 2025 and $10.1 million for Q4 2024.